Combination therapies for treating cancer with niraparib and PD-1 inhibitors Grant US-11661453-B2 United States of America 30 May 2023
COMBINATION THERAPIES FOR TREATING CANCER Application EP-3621592-A4 European Patent Office 17 Mar 2021